Fibroblast growth factor 21 is an endocrine metabolic hormone that regulates fuel adaptation, glucose utilization, lipid metabolism, fasting physiology, mitochondrial stress responses, and energy homeostasis. FGF21 acts as a nutrient-sensitive communication signal linking liver metabolism with adipose tissue, skeletal muscle, pancreas, and central nervous system pathways. The hormone supports fatty acid oxidation, ketogenesis, glucose handling, adaptive thermogenesis, and metabolic flexibility during changing nutritional conditions.
FGF21 becomes particularly important during fasting, ketogenic metabolism, amino acid restriction, and cellular stress states. It helps coordinate transitions between carbohydrate utilization and lipid-derived energy production. The hormone also influences adipokine signaling, sympathetic nervous system activity, and appetite-related pathways associated with macronutrient balance. In adipose tissue, FGF21 contributes to regulation of thermogenic signaling, lipid turnover, and endocrine communication.
FGF21 is produced primarily by hepatocytes in the liver, although additional expression can occur in adipose tissue, skeletal muscle, pancreas, heart, and additional organs during specific physiological states. It is synthesized as a secreted peptide hormone and released into circulation where it acts through fibroblast growth factor receptors together with the co-receptor beta-klotho.
Beta-klotho provides tissue specificity to FGF21 signaling because effective endocrine signaling depends on receptor-cofactor availability. Hepatic production rises substantially during fasting and fatty acid oxidation. Muscle-derived FGF21 may increase during mitochondrial stress and exercise-related adaptation, while adipose-derived FGF21 participates in local metabolic communication.
FGF21 production is regulated by fasting, ketogenic signaling, protein restriction, amino acid imbalance, carbohydrate intake, cold exposure, mitochondrial dysfunction, oxidative stress, and endoplasmic reticulum stress pathways. In the liver, PPAR-alpha strongly stimulates FGF21 expression during fasting and fatty acid oxidation. Carbohydrate-responsive element-binding protein pathways can also increase production in response to high carbohydrate intake.
FGF21 signaling activates pathways involving AMPK, adiponectin, sympathetic signaling, and mitochondrial metabolic regulation. The hormone interacts with circadian biology, nutrient sensing, thermogenic pathways, and central nervous system energy regulation. Through these integrated endocrine systems, FGF21 helps coordinate metabolic adaptation during changing nutrient environments, cellular stress conditions, and energy-demand fluctuations.
FGF21 helps the body switch fuels under fasting and macronutrient stress, supporting fatty-acid use and ketone handling.
